Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biotrack Inc.

Division of Novartis AG

Latest From Biotrack Inc.

Activx Biosciences Inc.

Activx Biosciences Inc. is positioning itself as a second-generation proteomics company with what it claims is the first high-throughput chemistry platform for activity-based proteomics. The company aims to convert the massive amounts of raw genomics data into targets for drug discovery by using chemical probes to directly measure protein activity.
BioPharmaceutical Strategy

Vascular Therapeutics Inc.

Vascular Therapeutics is developing drugs to treat clotting disorders at the molecular level.
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Novartis AG
  • Senior Management
  • Paul Balsara, VP, Finance & CFO
    Jim Allen, Pres.
    Jim Lavan, VP, Operations
    Michael Cobb, VP, Research & Development
  • Contact Info
  • Biotrack Inc.
    Phone: (415) 965-7400
    1058 Huff Avenue
    Mountain View, CA 94043